Nikolaos Antonakos
Athens, ESYE31 12462, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
A human-specific long noncoding RNA regulator of antigen-presenting cell viability and antimicrobial defense.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 16, 2026
Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial.
Journal: JAMA
Published: December 08, 2025
Blood Biomarker and Raman Analysis of Leukocytes in the Multicenter Intelligence Trials: At the Intensive Care Unit (Intelligence-1) and the Emergency Department (Intelligence-2).
Journal: Shock (Augusta, Ga.)
Published: September 25, 2025
Interleukin-6 is a mediator of therapeutic efficacy in acute lung injury.
Journal: American journal of respiratory and critical care medicine
Published: August 20, 2025
Interleukin-6 is a mediator of therapeutic efficacy in acute lung injury.
Journal: American journal of respiratory and critical care medicine
Published: August 20, 2025
Efficacy of anakinra in reducing progression to organ dysfunction in patients with pneumonia (INSPIRE): a randomised, double-blind, placebo-controlled, phase IIa trial.
Journal: The Lancet regional health. Europe
Published: May 03, 2025
Modulation of Metabolomic Profile in Sepsis According to the State of Immune Activation.
Journal: Critical care medicine
Published: October 17, 2024
Sepsis pathogenesis and outcome are shaped by the balance between the transcriptional states of systemic inflammation and antimicrobial response.
Journal: Cell reports. Medicine
Published: March 13, 2024
A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and CTLA4-Mediated Immune Dysregulation Syndrome in Greece.
Journal: Medicina (Kaunas, Lithuania)
Published: February 23, 2024
Regulation of plasma soluble receptors of TNF and IL-1 in patients with COVID-19 differs from that observed in sepsis.
Journal: The Journal of infection
Published: December 17, 2023
qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial.
Journal: Critical care (London, England)
Published: December 16, 2023
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Respiratory medicine
Published: July 28, 2023
Last Updated: 09/26/2026